vs

Side-by-side financial comparison of AdvanSix Inc. (ASIX) and COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI). Click either name above to swap in a different company.

AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $240.5M, roughly 1.5× COGENT COMMUNICATIONS HOLDINGS, INC.). AdvanSix Inc. runs the higher net margin — -0.8% vs -12.8%, a 12.0% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -4.7%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-43.0M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -4.9%).

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

Cogent Communications Holdings, Inc. is a multinational internet service provider based in the United States. Cogent's primary services consist of Internet access and data transport, offered on a fiber optic, IP data-only network, along with colocation in data centers.

ASIX vs CCOI — Head-to-Head

Bigger by revenue
ASIX
ASIX
1.5× larger
ASIX
$359.9M
$240.5M
CCOI
Growing faster (revenue YoY)
ASIX
ASIX
+14.1% gap
ASIX
9.4%
-4.7%
CCOI
Higher net margin
ASIX
ASIX
12.0% more per $
ASIX
-0.8%
-12.8%
CCOI
More free cash flow
ASIX
ASIX
$79.1M more FCF
ASIX
$36.1M
$-43.0M
CCOI
Faster 2-yr revenue CAGR
ASIX
ASIX
Annualised
ASIX
3.4%
-4.9%
CCOI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASIX
ASIX
CCOI
CCOI
Revenue
$359.9M
$240.5M
Net Profit
$-2.8M
$-30.8M
Gross Margin
7.6%
46.6%
Operating Margin
-0.7%
-4.7%
Net Margin
-0.8%
-12.8%
Revenue YoY
9.4%
-4.7%
Net Profit YoY
-892.9%
28.9%
EPS (diluted)
$-0.11
$-0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASIX
ASIX
CCOI
CCOI
Q4 25
$359.9M
$240.5M
Q3 25
$374.5M
$241.9M
Q2 25
$410.0M
$246.2M
Q1 25
$377.8M
$247.0M
Q4 24
$329.1M
$252.3M
Q3 24
$398.2M
$257.2M
Q2 24
$453.5M
$260.4M
Q1 24
$336.8M
$266.2M
Net Profit
ASIX
ASIX
CCOI
CCOI
Q4 25
$-2.8M
$-30.8M
Q3 25
$-2.6M
$-41.5M
Q2 25
$31.4M
$-57.8M
Q1 25
$23.3M
$-52.0M
Q4 24
$352.0K
$-43.3M
Q3 24
$22.3M
$-63.1M
Q2 24
$38.9M
$-32.3M
Q1 24
$-17.4M
$-65.3M
Gross Margin
ASIX
ASIX
CCOI
CCOI
Q4 25
7.6%
46.6%
Q3 25
6.8%
45.6%
Q2 25
14.3%
44.2%
Q1 25
14.2%
44.4%
Q4 24
3.4%
38.5%
Q3 24
14.4%
37.2%
Q2 24
17.9%
40.0%
Q1 24
0.9%
36.5%
Operating Margin
ASIX
ASIX
CCOI
CCOI
Q4 25
-0.7%
-4.7%
Q3 25
-0.9%
-7.5%
Q2 25
7.7%
-12.8%
Q1 25
7.7%
-16.3%
Q4 24
-3.9%
-13.2%
Q3 24
7.5%
-22.5%
Q2 24
11.5%
-18.1%
Q1 24
-7.0%
-22.3%
Net Margin
ASIX
ASIX
CCOI
CCOI
Q4 25
-0.8%
-12.8%
Q3 25
-0.7%
-17.2%
Q2 25
7.7%
-23.5%
Q1 25
6.2%
-21.1%
Q4 24
0.1%
-17.2%
Q3 24
5.6%
-24.5%
Q2 24
8.6%
-12.4%
Q1 24
-5.2%
-24.5%
EPS (diluted)
ASIX
ASIX
CCOI
CCOI
Q4 25
$-0.11
$-0.63
Q3 25
$-0.10
$-0.87
Q2 25
$1.15
$-1.21
Q1 25
$0.86
$-1.09
Q4 24
$0.02
$-0.89
Q3 24
$0.82
$-1.33
Q2 24
$1.43
$-0.68
Q1 24
$-0.65
$-1.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASIX
ASIX
CCOI
CCOI
Cash + ST InvestmentsLiquidity on hand
$19.8M
$148.5M
Total DebtLower is stronger
$1.7B
Stockholders' EquityBook value
$815.2M
$-63.8M
Total Assets
$1.7B
$3.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASIX
ASIX
CCOI
CCOI
Q4 25
$19.8M
$148.5M
Q3 25
$23.7M
$147.1M
Q2 25
$18.4M
$213.7M
Q1 25
$8.3M
$153.8M
Q4 24
$19.6M
$198.5M
Q3 24
$17.3M
$279.2M
Q2 24
$12.1M
$384.4M
Q1 24
$20.6M
$118.4M
Total Debt
ASIX
ASIX
CCOI
CCOI
Q4 25
$1.7B
Q3 25
Q2 25
Q1 25
Q4 24
$1.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASIX
ASIX
CCOI
CCOI
Q4 25
$815.2M
$-63.8M
Q3 25
$818.2M
$-39.2M
Q2 25
$823.7M
$46.7M
Q1 25
$794.4M
$142.8M
Q4 24
$774.6M
$222.8M
Q3 24
$766.4M
$323.6M
Q2 24
$746.6M
$415.5M
Q1 24
$713.2M
$500.6M
Total Assets
ASIX
ASIX
CCOI
CCOI
Q4 25
$1.7B
$3.1B
Q3 25
$1.7B
$3.1B
Q2 25
$1.6B
$3.3B
Q1 25
$1.6B
$3.1B
Q4 24
$1.6B
$3.2B
Q3 24
$1.5B
$3.2B
Q2 24
$1.5B
$3.3B
Q1 24
$1.5B
$3.1B
Debt / Equity
ASIX
ASIX
CCOI
CCOI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
6.53×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASIX
ASIX
CCOI
CCOI
Operating Cash FlowLast quarter
$63.7M
$-6.0M
Free Cash FlowOCF − Capex
$36.1M
$-43.0M
FCF MarginFCF / Revenue
10.0%
-17.9%
Capex IntensityCapex / Revenue
7.7%
15.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$6.4M
$-198.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASIX
ASIX
CCOI
CCOI
Q4 25
$63.7M
$-6.0M
Q3 25
$26.6M
$3.1M
Q2 25
$21.1M
$-44.0M
Q1 25
$11.4M
$36.4M
Q4 24
$64.2M
$14.5M
Q3 24
$57.3M
$-20.2M
Q2 24
$50.2M
$-22.2M
Q1 24
$-36.2M
$19.2M
Free Cash Flow
ASIX
ASIX
CCOI
CCOI
Q4 25
$36.1M
$-43.0M
Q3 25
$66.0K
$-33.1M
Q2 25
$-7.2M
$-100.2M
Q1 25
$-22.6M
$-21.7M
Q4 24
$29.8M
$-31.6M
Q3 24
$26.8M
$-79.5M
Q2 24
$16.7M
$-70.9M
Q1 24
$-71.6M
$-21.7M
FCF Margin
ASIX
ASIX
CCOI
CCOI
Q4 25
10.0%
-17.9%
Q3 25
0.0%
-13.7%
Q2 25
-1.7%
-40.7%
Q1 25
-6.0%
-8.8%
Q4 24
9.1%
-12.5%
Q3 24
6.7%
-30.9%
Q2 24
3.7%
-27.2%
Q1 24
-21.3%
-8.1%
Capex Intensity
ASIX
ASIX
CCOI
CCOI
Q4 25
7.7%
15.4%
Q3 25
7.1%
15.0%
Q2 25
6.9%
22.8%
Q1 25
9.0%
23.5%
Q4 24
10.4%
18.3%
Q3 24
7.7%
23.0%
Q2 24
7.4%
18.7%
Q1 24
10.5%
15.4%
Cash Conversion
ASIX
ASIX
CCOI
CCOI
Q4 25
Q3 25
Q2 25
0.67×
Q1 25
0.49×
Q4 24
182.29×
Q3 24
2.57×
Q2 24
1.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

CCOI
CCOI

Segment breakdown not available.

Related Comparisons